FRANCE-HEALTH-WOMEN-CONTRACEPTION : Fotografía de noticias

FRANCE-HEALTH-WOMEN-CONTRACEPTION

Crédito: 
MARTIN BUREAU / Fotógrafo de plantilla
Dominique Maraninchi, head of France's regulator the National Agency for the Safety of Drugs and Health Products (ANSM) speaks during a press conference on acne pill Diane 35, on January 30, 2013 in Paris. In the latest health scare to erupt in France, a drug watchdog on Wednesday announced it was suspending sales of an acne pill also used as a contraceptive after four women died and more than 100 others fell ill with blood clots. The National Agency for the Safety of Drugs and Health Products (ANSM) said it was suspending sales of a hormonal treatment called Diane-35, which is prescribed to 315,000 women in France. the product, made by the German firm Bayer, is authorised for treating acne in young women, but doctors have been prescribing it as a contraceptive because it stops ovulation, he said. AFP PHOTO MARTIN BUREAU (Photo credit should read MARTIN BUREAU/AFP/Getty Images)
Leyenda:
Dominique Maraninchi, head of France's regulator the National Agency for the Safety of Drugs and Health Products (ANSM) speaks during a press conference on acne pill Diane 35, on January 30, 2013 in Paris. In the latest health scare to erupt in France, a drug watchdog on Wednesday announced it was suspending sales of an acne pill also used as a contraceptive after four women died and more than 100 others fell ill with blood clots. The National Agency for the Safety of Drugs and Health Products (ANSM) said it was suspending sales of a hormonal treatment called Diane-35, which is prescribed to 315,000 women in France. the product, made by the German firm Bayer, is authorised for treating acne in young women, but doctors have been prescribing it as a contraceptive because it stops ovulation, he said. AFP PHOTO MARTIN BUREAU (Photo credit should read MARTIN BUREAU/AFP/Getty Images)
Calcular precioVer carrito
Fecha de creación:
30 de enero de 2013
Editorial n.º:
160367860
Restricciones:
Póngase en contacto con su oficina local para conocer todos los usos con fines comerciales o promocionales. Derechos editoriales plenos en Reino Unido, EE.UU., Irlanda, Italia, España y Canadá (excepto Québec). Si desea conocer los derechos editoriales restringidos en otro país, llame a su oficina local.
Tipo de licencia:
Con derechos gestionadosLas licencias de productos con derechos gestionados se negocian según el uso que se les dé. La tarifa para utilizar el producto se calcula a partir de diversos factores, entre los que se encuentran el tamaño, la colocación, la duración del uso y la distribución geográfica. Cuando decidas completar la compra de un producto con derechos gestionados, te pediremos información para determinar los derechos de uso.
Colección:
AFP
Tamaño máx. archivo:
4.928 x 3.280 px (173,85 x 115,71 cm) - 72 dpi - 5 MB
Inf. de autorización:
No se cuenta con autorizaciones.Más información
Fuente:
AFP
Código de barras:
AFP
Nombre del objeto:
Par7459308

Palabras clave

Esta imagen está sujeta a copyright. Getty Images se reserva el derecho a demandar a los usuarios no autorizados de esta imagen o este clip, y a reclamar daños y perjuicios por violación de derechos de autor. No se podrá garantizar la disponibilidad de esta imagen hasta el momento de la compra.
Dominique Maraninchi head of France's regulator the National Agency... Fotografía de noticias 160367860Asistencia sanitaria y medicina,Cabeza,Conferencia de prensa,Diane,Francia,Hablar,Horizontal,París,PíldorasPhotographer Collection: AFP 2013 AFPDominique Maraninchi, head of France's regulator the National Agency for the Safety of Drugs and Health Products (ANSM) speaks during a press conference on acne pill Diane 35, on January 30, 2013 in Paris. In the latest health scare to erupt in France, a drug watchdog on Wednesday announced it was suspending sales of an acne pill also used as a contraceptive after four women died and more than 100 others fell ill with blood clots. The National Agency for the Safety of Drugs and Health Products (ANSM) said it was suspending sales of a hormonal treatment called Diane-35, which is prescribed to 315,000 women in France. the product, made by the German firm Bayer, is authorised for treating acne in young women, but doctors have been prescribing it as a contraceptive because it stops ovulation, he said. AFP PHOTO MARTIN BUREAU (Photo credit should read MARTIN BUREAU/AFP/Getty Images)